SBI Securities’s Eterna Therapeutics ERNA Stock Holding History

SBI Securities’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3	Hold	1	–	–	﹤0.01%	4074
2026 Q2	$7	Buy	+1	New	+$7	﹤0.01%	3945
2026 Q1	–	Hold	0	–	–	–	3979
2025 Q2	–	Hold	0	–	-$2	–	4167
2025 Q1	–	Hold	0	–	–	–	4089
2024 Q4	–	Hold	0	–	–	–	4035

Other funds holding ERNA

Tradewinds Capital Management Bellingham, Washington $578M AUM 35.02% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

SBI Securities's ERNA Position: Q3 2026 in Review

SBI Securities held its Eterna Therapeutics (ERNA) position steady in Q3 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #4074.

SBI Securities first reported a position in ERNA in Q2 2026 and has held it in 2 quarters since. The position peaked at $7 in Q2 2026. 3 funds tracked by Wall St. Rank hold ERNA as of Q3 2026.

SBI Securities held 1 share of Eterna Therapeutics worth $3 as of Q3 2026.
SBI Securities left its Eterna Therapeutics share count unchanged in Q3 2026.
Eterna Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4074 holding.
SBI Securities first reported a position in Eterna Therapeutics in Q2 2026 and has held it in 2 quarters since.
SBI Securities's Eterna Therapeutics position peaked at $7 in Q2 2026.
3 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.